Bionano Genomics, Inc. (BNGO)

NASDAQ

$1.21

$+0.02

(+1.85%)

Pre-Market

Bionano Genomics, Inc. (BNGO) Live Price Chart

Last updated: ⁦2026-11-03 09:05:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Bionano Genomics, Inc. (BNGO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $1.21, with a market capitalization of $16.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.00 to $2.23. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$16.07M
Open	$1.19
Day's High	$9,414.00
Day's Low	$1.00
Previous Close	$1.16
Volume	37.00
Average Volume	955.73K
P/E Ratio	--
52-Week High	$2.23
52-Week Low	$1.00
Dividend Yield	--
Earnings Date	--

Bionano Genomics, Inc. (BNGO) Pre-Market Stock Price

Bionano Genomics, Inc. (BNGO) is trading at $1.21 in pre-market trading as of 2026-11-03 09:02:00, up 4.14% ($0.05) from the previous close of $1.16

Pre-market trading shows how investors are pricing BNGO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Bionano Genomics, Inc. (BNGO) 7-Day Stock Price Change

Over the past seven days, Bionano Genomics, Inc. (BNGO) moved from $1.13 to $1.21, representing a gain of 6.90% ($0.08).

The stock traded between $1.10 and $1.25 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 122.15 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BNGO 52-Week Price Position

Position in Range: 16.9%

52W Low$1.00

52W High$2.23

BNGO is currently trading at $1.21, placing it 16.9% of the way from its 52-week low of $1.00 to its 52-week high of $2.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bionano Genomics, Inc. (BNGO)?

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Bionano Genomics, Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	97
Exchange	NASDAQ
Company Website	https://www.bionano.com

How to Buy Bionano Genomics, Inc. (BNGO) Stock on MEXC

Eligible investors can buy real shares of Bionano Genomics, Inc. (BNGO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BNGO and Place Your Order

Open the RealStocks trading page and search for BNGO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bionano Genomics, Inc. (BNGO) stock price today?

Bionano Genomics, Inc. (BNGO) is currently trading at $ 1.21, up 4.14% ($0.05) from the previous close of $ 1.16. Intraday prices update in real time during regular trading hours.

2.Is BNGO stock going up or down today?

As of 2026-11-03 09:02:00, BNGO is trading at $ 1.21, up 4.14% ($0.05) from its previous close of $ 1.16. The stock has traded between $ 1.00 and $ 9,414.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is BNGO pre-market price?

As of 2026-11-03 09:02:00, BNGO is trading at $ 1.21 in pre-market trading, up 4.14% ($0.05) from the previous close of $ 1.16. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BNGO after-hours price?

As of 2026-11-03 09:02:00, BNGO is trading at $ 1.19 in after-hours trading, up 2.24% ($0.03) from the regular-session close of $ 1.16. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BNGO stock trading now?

BNGO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BNGO sit relative to its 52-week high and low?

Over the past 52 weeks, BNGO has traded between a low of $ 1.00 and a high of $ 2.23. At $ 1.21, the stock is positioned 16.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bionano Genomics, Inc. in?

Bionano Genomics, Inc. (BNGO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bionano Genomics, Inc.'s market capitalization and where is it listed?

Bionano Genomics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 16.07M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BNGO valued in terms of P/E ratio and EPS?

BNGO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.30. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bionano Genomics, Inc. pay a dividend?

Bionano Genomics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.